Picture shown is for illustration purpose only. Actual product may vary due to product enhancement.

Picture shown is for illustration purpose only. Actual product may vary due to product enhancement.

 

Introducing N-SENSE
Our Novel ENG Platform Technology


Features & Benefits

Multi-channel hardware designed to sense & stimulate nerves.

Simultaneous stimula-  tion and measure for  optimal closed loop  feedback system

Aid in targeting nerve location.

Algorithms tailored to specific applications.

Assess nerve for hyperactivity.

Catheter-agnostic interface.

Reducing hypertension through effective, faster, safer procedures

Our first product focuses on improving the safety and efficacy of renal denervation procedures.

Screen Shot 2021-03-02 at 4.24.34 PM.png

Renal Denervation Quick Facts

Renal denervation is a minimally invasive, end-vascular catheter-based procedure using radio frequency ablation or ultrasound ablation aimed at treating resistant hypertension. Renal denervation has proven to be effective in reducing hypertension, but clinical endpoints are still suboptimal.

  • There are 2.6 million people in the U.S. that suffer with hypertension and 7.4 million in the rest of the world.

  • Hypertension is the single largest contributor to death.

  • Half of all diagnosed patients are non-adherent to their medical therapy within a year of initiating.

  • Two-thirds of cases remain uncontrolled despite the availability of drugs.

  • Renal denervation devide market is expected to reach $7B by 2021 (CAGR 23.7%)*

    *Source:iHealthcareAnalyst, Inc. Feb. 2020


OUR VALUE ADD

Greater reduction in ambulatory blood pressure through introduction of a feedback loop for optimal ablation outcomes  

 

Determine procedural need i.e. neurogenic causation

Determine completeness of ablation procedures

Deliver faster and safer procedures.

Addressing chronic pain

In the United States only, an estimated 20.4% of adults (50M) suffer from chronic pain and 8.0% (19.6M) high-impact pain*. This leads to significant disruptions, including dependence on opioids, anxiety and depression, poor health, or reduced quality of life.

Screen Shot 2021-03-03 at 2.28.01 PM.png

Closed Loop Ablation can help better target chronic pain

  • Afferent medial branch nerves: facet joint pain, lumbar pain, arthritis, spinal stenosis

  • Stellate ganglia: acute ischemia, CRPS, neuralgia

  • Peripheral nerves: carpal tunnel, peripheral neuropathy

  • DRG: Intercostal neuralgia, neck pain, back pain, limb


OUR VALUE ADD

Closed loop ablation may be the optimal therapeutic choice to reduce chronic pain 

 

Closed loop ablation vs. drug therapy

  • Reduced need and dependency for opiate analgesics

  • Reduced side effects associated with opiate analgesics

  • Addiction rate is approximately 10%, with 20-30% of prescribed opioids for pain management being misused**

Closed loop ablation vs. neurostimulation

  • Contraindications: ICD, pacemaker, MRI, ability to operate

  • Complications: lead migration, infection, rejection of the device, and new pain arising at the implant site

  • Explant and/or replacement requiring additional surgery

Product Development Timeline 2021/22

 

NSense product development timeline.jpg